Quince Therapeutics News - QNCX

Stock Name Stock Symbol Market Stock Type
Quince Therapeutics Inc QNCX NASDAQ Common Stock
  Price Change Price Change % Stock Price Last Trade
0.00 0.0% 1.33 05:02:23
Open Price Low Price High Price Close Price Previous Close
more quote information »

Recent News

Date Time Source Heading
9/16/202207:00BWQuince Therapeutics Presents Preclinical Data at MHSRS 2022..
9/12/202207:00BWQuince Therapeutics Presents Preclinical Data at ASBMR 2022..
9/08/202216:59EDGARStatement of Changes in Beneficial Ownership (4)
8/30/202215:05BWQuince Therapeutics Presents Preclinical Data at OI 2022..
8/25/202215:05BWQuince Therapeutics to Present at Upcoming Scientific..
8/09/202215:28EDGARQuarterly Report (10-q)
8/04/202207:00BWQuince Therapeutics to Present at Canaccord Genuity 42nd..
8/01/202208:17EDGARCurrent Report Filing (8-k)
7/27/202207:01BWCortexyme Corporate Name Change to Quince Therapeutics to..
7/27/202207:00BWCortexyme Successfully Completes Phase 1 Single and Multiple..
7/22/202215:26EDGARCurrent Report Filing (8-k)
7/08/202211:57EDGARSchedule 13g
(sc 13g/a)
7/01/202216:03EDGARStatement of Changes in Beneficial Ownership (4)
6/21/202207:00BWCortexyme Announces Preclinical Data Demonstrating Efficacy..
6/13/202207:00BWCortexyme Appoints June Bray to its Board of Directors
6/10/202216:02EDGARCurrent Report Filing (8-k)
6/08/202215:14EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202215:11EDGARStatement of Changes in Beneficial Ownership (4)
6/08/202215:10EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202217:17EDGARAmended Statement of Changes in Beneficial Ownership (4/a)
5/25/202215:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/20/202215:08EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/20/202207:16EDGARCurrent Report Filing (8-k)
5/20/202207:01BWCortexyme Appoints Dr. Philip Low to Its Board of Directors
5/20/202207:00BWCortexyme Successfully Completes Acquisition of Novosteo
5/19/202215:46EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
5/18/202205:08EDGARNotice of Effectiveness (effect)
5/17/202205:06EDGARPost-effective Amendment Filed Solely to Add Exhibits to a..
5/12/202216:13EDGARCurrent Report Filing (8-k)
5/12/202207:00BWCortexyme to Participate at 4th International Conference on..
5/11/202211:45TRMNCredit Suisse Reaffirms Their Sell Rating on Cortexyme..
5/10/202207:09EDGARCurrent Report Filing (8-k)
5/10/202207:00BWCortexyme Announces Agreement to Acquire Novosteo
4/27/202215:04EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/27/202215:04EDGARProxy Statement (definitive) (def 14a)
3/22/202205:26TRMNCortexyme (CRTX) Gets a Buy Rating from H.C. Wainwright
3/21/202207:00BWCortexyme Provides New GAIN Trial Data at AD/PD 2022..
3/16/202217:34EDGARStatement of Changes in Beneficial Ownership (4)
3/16/202217:30EDGARInitial Statement of Beneficial Ownership (3)
3/15/202207:00BWCortexyme Appoints Marwan Sabbagh, MD, to its Board of..
3/14/202207:00BWCortexyme to Present New GAIN Trial Data at AD/PD 2022
3/09/202207:00BWCortexyme Announces Preclinical Data Highlighting Potential..
3/09/202205:24TRMNH.C. Wainwright Thinks Cortexyme’s Stock is Going to Recover
3/08/202213:15TRMNCortexyme (CRTX) Gets a Hold Rating from JMP Securities
3/08/202207:35SEEKCortexyme COR588 for bacterial infection shows safety in..
3/08/202207:00BWCortexyme Reports Safety and Pharmacokinetics Results from..
3/04/202216:59EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202216:58EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202216:56EDGARStatement of Changes in Beneficial Ownership (4)
3/04/202216:48EDGARStatement of Changes in Beneficial Ownership (4)
Your Recent History
Quince The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20221003 10:54:32